Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Equities Mixed, Commodities Hold Steady, Eyes on Jobs Data and Fed Policy

Index Update:The Dow Jones rose 0.91% on Tuesday, driven by strong gains in healthcare stocks like UnitedHealth and Amgen. In contrast, the S&P 500 and Nasdaq fell due to a sharp selloff in tech shares, with notable losses in Nvidia, Tesla, and Palantir. On …

Team Kalkine | 02 July 2025

Goldman Sachs Upgrades Hasbro (NASDAQ:HAS) to “Buy,” Raises Price Target

Goldman Sachs has upgradedHasbro, Inc. (NASDAQ:HAS - Get Free Report)to a “Buy” rating from its previous “Neutral” stance, while lifting its price target to USD85 from USD66. The firm’s revised outlook reflects optimism about Hasbro’s growing digital and tabletop gaming division and the resilience …

Team Kalkine | 02 July 2025

Coterra Energy (NYSE:CTRA) Holds “Moderate Buy” Consensus Despite Mixed Analyst Price Targets

Coterra Energy (NYSE:CTRA - Get Free Report)continues to carry a consensus rating of “Moderate Buy,” according to data from MarketBeat, despite recent mixed signals from Wall Street analysts. Out of 22 analysts tracking the company, five have assigned hold ratings, sixteen have issued buy …

Team Kalkine | 02 July 2025

Tutor Perini (NYSE: TPC) Secures $220 Million Contract for Eagle Mountain Casino Expansion

Tutor Perini Corporation (NYSE: TPC) announced that its subsidiary, Tutor Perini Building Corp., has been awarded a USD220 million contract for Phase 2 of the Eagle Mountain Casino expansion. Commissioned by the Tule River Gaming Authority, the development includes a wide range of hospitality …

Team Kalkine | 02 July 2025

KKR (NYSE: KKR) to Acquire ProTen, One of Australia's Largest Poultry Infrastructure Operators

KKR (NYSE: KKR)has entered into definitive agreements to acquire ProTen Pty Limited, a major agricultural infrastructure business focused on Australia’s poultry supply chain. The acquisition will be made through funds managed by KKR, purchasing the company from Aware Super, one of Australia’s largest superannuation …

Team Kalkine | 02 July 2025

Coupang (NYSE: CPNG) Rebrands AI Infrastructure as Coupang Intelligent Cloud (CIC)

Coupang Inc. (NYSE: CPNG)has rebranded its artificial intelligence cloud computing platform as Coupang Intelligent Cloud (CIC), reflecting ongoing development of its internal AI capabilities and commercial infrastructure offerings. The platform has supported the company’s operations for years and now provides GPU-as-a-Service (GPUaaS), including availability …

Team Kalkine | 02 July 2025

Ingersoll Rand (NYSE: IR) Acquires TMIC and Adicomp in EUR160Mn Transaction

Ingersoll Rand Inc. (NYSE: IR)has acquired Termomeccanica Industrial Compressors S.p.A. (TMIC) and its subsidiary Adicomp S.p.A. in a transaction valued at around EUR160 million. The company stated that the purchase was made at a low-double-digit multiple and is expected to result in a mid-to-high …

Team Kalkine | 02 July 2025

Hamilton Lane (Nasdaq: HLNE) Unveils Asia Private Assets Fund Targeting USD 3Tn Regional Market

Hamilton Lane (Nasdaq: HLNE)has launched the Hamilton Lane Asia Private Assets Fund (HLAPA), a new evergreen investment vehicle targeting private market opportunities across Asia. The semi-liquid fund is designed to give private wealth and institutional investors access to diversified private equity investments in a …

Team Kalkine | 02 July 2025

Daily Market Recap: Stocks Rise, Yields Fall, and Commodities React to Trade and Fiscal Developments

Index Update:U.S. stocks advanced on Monday, with the S&P 500, Nasdaq, and Dow all posting gains, driven by strong performances in Big Tech and easing trade tensions after Canada withdrew its proposed digital services tax. Investor optimism was further boosted by hopes for new …

Team Kalkine | 01 July 2025

Mesoblast (Nasdaq: MESO) and FDA Align on Key Filing Components for Revascor® Biologics License Application

Mesoblast (Nasdaq: MESO; ASX: MSB)announced that it has reached alignment with the U.S. Food and Drug Administration (FDA) on key components required to file a Biologics License Application (BLA) for its cell therapy candidate Revascor® (rexlemestrocel-L) for the treatment of ischemic heart failure with …

Team Kalkine | 30 June 2025
Support

Hi! How can we help you today?

Loading…